Home › Funds › Headland Capital, LLC › BSX
Headland Capital, LLC position in BSX
Boston Scientific Corp · Health Care
Headland Capital, LLC reported holding 62,652 shares of BSX (Boston Scientific Corp) in its Q3 2026 13F filing — a position valued at US$2.7M, representing 0.68% of its reported portfolio and ranking #20 among its reported holdings. Headland Capital, LLC has disclosed BSX holdings in 8 of the last 8 reported quarters, going back to Q4 2024.
Last updated: 2026-11-06 · Source: SEC EDGAR Form 13F-HR
How Headland Capital, LLC's BSX position evolved
Headland Capital, LLC first disclosed a stake in BSX in Q4 2024 at 88,886 shares (US$7.9M). The position peaked in Q2 2025 at 89,704 shares, worth US$9.6M. Across 8 filings, Headland Capital, LLC increased the stake 4 time(s), trimmed it 2 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 62,652 shares valued at US$2.7M — a reduction of -42,461 shares quarter over quarter.. Notable position changes include a 40% trim in Q3 2026 (shares rose 2% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2024 | 88.89K | $7.94M | New |
| Q1 2025 | 88.26K | $8.90M | Reduce |
| Q2 2025 | 89.70K | $9.64M | Add |
| Q3 2025 | 90.64K | $8.85M | Add |
| Q4 2025 | 90.51K | $8.63M | Hold |
| Q1 2026 | 94.26K | $5.91M | Add |
| Q2 2026 | 105.11K | $4.49M | Add |
| Q3 2026 | 62.65K | $2.73M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About BSX and 13F data
BSX (Boston Scientific Corp) is a Health Care company. 20 other funds we track also report a position in BSX — the largest reported positions include Banque Cantonale Vaudoise (US$2.89B), PRIMECAP MANAGEMENT CO/CA/ (US$2.16B), D. E. Shaw & Co (US$1.16B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding BSX
- Banque Cantonale Vaudoise 67.61K sh · $2.89B · Q2 2026
- PRIMECAP MANAGEMENT CO/CA/ 50.52M sh · $2.16B · Q2 2026
- D. E. Shaw & Co 27.27M sh · $1.16B · Q2 2026
- Janus Henderson Group 16.50M sh · $1.04B · Q1 2026
- Arrowstreet Capital 23.29M sh · $994.18M · Q2 2026
- Bollard Group LLC 18.42M sh · $786.20M · Q2 2026
More on Headland Capital, LLC
FAQ
How long has Headland Capital, LLC held BSX?
Headland Capital, LLC has disclosed BSX holdings in 8 of the last 8 reported quarters, going back to Q4 2024.
What is Headland Capital, LLC's current position in BSX?
As of Q3 2026, Headland Capital, LLC holds 62.65K shares of BSX (Boston Scientific Corp), valued at $2.73M, representing 0.68% of its reported portfolio and ranking #20.
Has Headland Capital, LLC been buying or selling BSX?
In the latest 13F filing (Q3 2026), Headland Capital, LLC reduced its position in BSX. The position peaked in Q2 2025 at 89.70K shares.
Which other funds hold BSX?
Other major institutional holders of BSX include Banque Cantonale Vaudoise, PRIMECAP MANAGEMENT CO/CA/, D. E. Shaw & Co, among 20 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.